Phinomics
San Carlos
About Phinomics
Phinomics is a precision-medicine platform company, focused on exploiting unique circular-DNA targets for precision care and identification of new therapeutics. Our discovery is grounded in reproducible science, novel technologies, proprietary workflows, and informatics/AI. Our platform enables rigorous identification of novel pathology-specific circular-DNAs and clinical validation of the previously-hidden targets to address unmet needs with unprecedented resolution.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (May 2022)
- Website: phinomics.com
- Phone: [email protected]
Industries & Categories
Bioinformatics, Biotechnology, Genetics, Health Care, Health Diagnostics
Social Profiles
Canonical: https://fsome.com/organization/phinomics-130052 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.